Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile Jan 10, 2012 02:57PM
Brean Murray Carret & Co. Downgrades Pharmasset (VRUS) to Hold; Near-Perfect Fit Nov 22, 2011 10:50AM
Brean Murray Carret Raises Price Target on Inhibitex (INHX) following INX-189 Data Nov 7, 2011 10:27AM
Pharmasset (VRUS) Shares Higher Following Results of PSI-7977 Trial; Analyst Weighs In Nov 7, 2011 08:59AM
Brean Murray Carret & Co. Maintains a 'Buy' Pharmasset (VRUS); Abbott (ABT) Hep C Pipeline Not More Risky Than Any Other Four Drug Combo Oct 24, 2011 10:21AM


Oct 10, 2011 11:03AM Brean Murray Carret & Co. Maintains a 'Buy' on Pharmasset (VRUS); Further ELECTRON Expansion Is a Positive Signal
Sep 7, 2011 11:37AM Brean Murray Carret Raises Price Target on Pharmasset (VRUS) Following Positive SVR12 News
Jun 2, 2011 09:49AM Brean Murray Carret & Co. Starts Inhibitex (INHX) at Buy, $6 Price Target
Jun 2, 2011 09:31AM Brean Murray Carret & Co. Starts Pharmasset (VRUS) at Buy, Price Target Offers 79% Upside